Gratus Capital LLC Cognition Therapeutics Inc Call Options Transaction History
Gratus Capital LLC
- $2.39 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CGTX
# of Institutions
50Shares Held
13.4MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$3.18 Million4.39% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$1.17 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.24MShares$656,9700.0% of portfolio
-
Sigma Planning Corp Ann Arbor, MI614KShares$325,6790.01% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$265,0000.0% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $12M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...